Insulet (PODD) Net Shares Issued and Repurchased (2011 - 2012)
Insulet's (PODD) quarterly Net Shares Issued and Repurchased came in at $121552.0 in Q4 2012, down 7.77% on a YoY basis from $131787.0 in Q1 2012, and up 374.98% quarter-over-quarter from $25591.0 in Q1 2012.
Powered by 
Analysis
Insulet (PODD) Net Shares Issued and Repurchased (2011 - 2012) Analysis & Trends
Insulet (PODD) has reported Net Shares Issued and Repurchased for 2 consecutive years, with $121552.0 the latest figure, recorded in Q4 2012.
- For the quarter ending Q4 2012, Net Shares Issued and Repurchased fell 7.77% year-over-year to $121552.0; the trailing twelve-month figure through Dec 2012 stood at $121552.0 (down 7.77% YoY), and the FY2012 full-year result was $121552.0, down 7.77% from the prior year.
- Net Shares Issued and Repurchased improved to $121552.0 in Q4 2012 per PODD's latest filing, from $25591.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $131787.0 in Q4 2011 and bottomed at $25591.0 in Q1 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | - |
| 10 | Insulet | 9.31 Bn | 8.77 Bn | 562.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2012 | 121,552.00 |
| Mar 31, 2012 | 25,591.00 |
| Dec 31, 2011 | 131,787.00 |